Literature DB >> 1955163

Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up.

T Rokkas1, M I Filipe, G E Sladen.   

Abstract

Because early gastric cancer is associated with a much better prognosis than advanced disease, its diagnosis is important. Over a 12 year period (1976-87), a progressive increase in the incidence of early gastric cancer was observed. Twenty four of the 718 (3.3%) consecutive gastric resections for gastric cancer in this period were in patients with early gastric cancer. Six of the 24 were diagnosed in the first six year period (1976-81) and 18 in the second six year period (1982-87) (p less than 0.01). This increase was observed during the prospective phase of the study, when all patients diagnosed on initial biopsy specimen as showing type III intestinal metaplasia underwent follow up endoscopy and biopsy at six to 12 month intervals. Eleven of the 18 with early gastric cancer detected in this period were diagnosed as a direct result of this follow up. We conclude that early gastric cancer can be diagnosed with increasing frequency if patients with type III intestinal metaplasia are closely followed endoscopically.

Entities:  

Mesh:

Year:  1991        PMID: 1955163      PMCID: PMC1379368          DOI: 10.1136/gut.32.10.1110

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Observations on the healing of ulcerations in early gastric cancer. The life cycle of the malignant ulcer.

Authors:  T Sakita; Y Oguro; S Takasu; H Fukutomi; T Miwa
Journal:  Gastroenterology       Date:  1971-05       Impact factor: 22.682

2.  Intestinal metaplasia in endoscopic biopsy specimens of gastric mucosa.

Authors:  G A Rothery; D W Day
Journal:  J Clin Pathol       Date:  1985-06       Impact factor: 3.411

3.  The endoscopic diagnosis of early gastric cancer.

Authors:  Y Ito; M O Blackstone; R H Riddell; J B Kirsner
Journal:  Gastrointest Endosc       Date:  1979-08       Impact factor: 9.427

4.  Variants of intestinal metaplasia in the evolution of chronic atrophic gastritis and gastric ulcer. A follow up study.

Authors:  S Silva; M I Filipe; A Pinho
Journal:  Gut       Date:  1990-10       Impact factor: 23.059

5.  Intestinal metaplasia with colonic-type sulphomucins in the gastric mucosa; its association with gastric carcinoma.

Authors:  P Sipponen; K Seppälä; K Varis; L Hjelt; T Ihamäki; M Kekki; M Siurala
Journal:  Acta Pathol Microbiol Scand A       Date:  1980-07

6.  Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres.

Authors:  M I Filipe; F Potet; W V Bogomoletz; P A Dawson; B Fabiani; P Chauveinc; A Fenzy; B Gazzard; D Goldfain; R Zeegen
Journal:  Gut       Date:  1985-12       Impact factor: 23.059

7.  Surgical treatment of early gastric cancer.

Authors:  H Kitaoka; K Yoshikawa; T Hirota; M Itabashi
Journal:  Jpn J Clin Oncol       Date:  1984-06       Impact factor: 3.019

8.  Early gastric cancer.

Authors:  P H Green; K M O'Toole; L M Weinberg; J P Goldfarb
Journal:  Gastroenterology       Date:  1981-08       Impact factor: 22.682

9.  Clinicopathological staging of gastric cancer.

Authors:  J W Fielding; C Roginski; D J Ellis; B G Jones; J Powell; J A Waterhouse; V S Brookes
Journal:  Br J Surg       Date:  1984-09       Impact factor: 6.939

10.  Gastric epithelial dysplasia in relapsing and nonrelapsing gastric ulcer.

Authors:  R Farini; F Farinati; G Leandro; F Di Mario; A Cecchetto; R Naccarato
Journal:  Am J Gastroenterol       Date:  1982-11       Impact factor: 10.864

View more
  62 in total

1.  Guidelines for the management of oesophageal and gastric cancer.

Authors:  W H Allum; S M Griffin; A Watson; D Colin-Jones
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

2.  Spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia: time for reevaluation of metaplasias and the origins of gastric cancer.

Authors:  James R Goldenring; Ki Taek Nam; Timothy C Wang; Jason C Mills; Nicholas A Wright
Journal:  Gastroenterology       Date:  2010-05-05       Impact factor: 22.682

3.  Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia.

Authors:  Tetsuya Tsukamoto; Kenichi Inada; Harunari Tanaka; Tsutomu Mizoshita; Mami Mihara; Toshikazu Ushijima; Yoshitaka Yamamura; Shigeo Nakamura; Masae Tatematsu
Journal:  J Cancer Res Clin Oncol       Date:  2003-12-04       Impact factor: 4.553

4.  Proliferative activity of gastric epithelium in progressive stages of Helicobacter pylori infection.

Authors:  C Panella; E Ierardi; L Polimeno; T Balzano; M Ingrosso; A Amoruso; A Traversa; A Francavilla
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

5.  Comparison of precancerous conditions: atrophy and intestinal metaplasia in Helicobacter pylori gastritis among Chinese and Dutch patients.

Authors:  X Y Chen; R W van Der Hulst; Y Shi; S D Xiao; G N Tytgat; F J Ten Kate
Journal:  J Clin Pathol       Date:  2001-05       Impact factor: 3.411

Review 6.  Pathology of gastric intestinal metaplasia: clinical implications.

Authors:  Pelayo Correa; M Blanca Piazuelo; Keith T Wilson
Journal:  Am J Gastroenterol       Date:  2010-03       Impact factor: 10.864

7.  Endoscopic diagnosis of open-type atrophic gastritis is related to the histological diagnosis of intestinal metaplasia and Cdx2 expression.

Authors:  Su Young Ahn; Sun-Young Lee; Sung Noh Hong; Jeong Hwan Kim; In-Kyung Sung; Hyung Seok Park; Chan Sup Shim; Choon Jo Jin; Hye Seung Han
Journal:  Dig Dis Sci       Date:  2011-01-08       Impact factor: 3.199

Review 8.  Redefining early gastric cancer.

Authors:  Savio G Barreto; John A Windsor
Journal:  Surg Endosc       Date:  2015-04-01       Impact factor: 4.584

9.  Premalignant lesions in gastric cancer.

Authors:  Kazuo Yashima; Shuji Sasaki; Masaharu Koda; Koichiro Kawaguchi; Kenichi Harada; Yoshikazu Murawaki
Journal:  Clin J Gastroenterol       Date:  2009-12-16

Review 10.  Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence.

Authors:  Carlos A González; José M Sanz-Anquela; Javier P Gisbert; Pelayo Correa
Journal:  Int J Cancer       Date:  2013-02-05       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.